5-<4-(1,1-Dimethylethyl)phenyl>thiophene-2-carboxylic acid | 115933-20-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 5-<4-(1,1-Dimethylethyl)phenyl>thiophene-2-carboxylic acid
• 英文别名: 2-Carboxy-5-[4-(1,1-dimethylethyl)phenyl]thiophene；5-(4-(Tert-butyl)phenyl)thiophene-2-carboxylic acid；5-(4-tert-butylphenyl)thiophene-2-carboxylic acid
• CAS: 115933-20-5
• 化学式: C₁₅H₁₆O₂S
• mdl: MFCD06801935
• 分子量: 260.357
• InChiKey: MHVSTLSQGKGLDB-UHFFFAOYSA-N

物化性质

• 沸点：
  404.5±33.0 °C(predicted)
• 密度：
  1.165±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.8
• 重原子数：
  18
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.266
• 拓扑面积：
  65.5
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  5-<4-(1,1-Dimethylethyl)phenyl>thiophene-2-carboxylic acid 在 叠氮磷酸二苯酯 、 三乙胺 作用下， 以 N,N-二甲基甲酰胺 、 甲苯 为溶剂， 反应 3.0h， 生成 2-<4-(1,1-Dimethylethyl)phenyl>5-isocyanatothiophene
  参考文献：
  名称：

  Axton, Christopher A.; Billingham, Michael E. J.; Bishop, Paul M., Journal of the Chemical Society. Perkin transactions I, 1992, # 17, p. 2203 - 2214

  摘要：

  DOI：
• 作为产物：
  描述：

  4-叔丁基溴苯 在 1,3-bis[(diphenylphosphino)propane]dichloronickel(II) 正丁基锂 、 magnesium 作用下， 反应 21.25h， 生成 5-<4-(1,1-Dimethylethyl)phenyl>thiophene-2-carboxylic acid
  参考文献：
  名称：

  Axton, Christopher A.; Billingham, Michael E. J.; Bishop, Paul M., Journal of the Chemical Society. Perkin transactions I, 1992, # 17, p. 2203 - 2214

  摘要：

  DOI：

文献信息

• Pharmaceutical compounds
  申请人：Lilly Industries Limited

  公开号：US04983619A1

  公开（公告）日：1991-01-08

  Compounds of the following formula have pharmaceutical properties: ##STR1## in which X is R'(HO)C.dbd.C(CN)--, R.sup.1 (CO)--CH(CN)-- or ##STR2## R.sup.1 and R.sup.2 are each hydrogen or C.sub.1-6 alkyl, R.sup.3, R.sup.4, R.sup.5 and R.sup.6 are each hydrogen, hydroxy, halogen, nitro, cyano, carboxy, C.sub.1-4 alkyl, C.sub.1-4 alkoxy, C.sub.1-4 alkylthio, halo-substituted C.sub.1-4 alkyl, halo-substituted C.sub.1-4 alkoxy, halo-substituted C.sub.1-4 alkylthio, C.sub.2-5 alkoxycarbonyl, optionally substituted phenyl, optionally substituted phenoxy, R'R"N-- where R' and R" are each hydrogen or C.sub.1-4 alkyl or R'"CONH-- where R'" is C.sub.1-4 alkyl, or a group of the formula --CR.sup.7 R.sup.8 R.sup.9 in which R.sup.7, R.sup.8 and R.sup.9 are each C.sub.1-6 alkyl, halo-substituted C.sub.1-6 alkyl or optionally substituted phenyl, or R.sup.7 and R.sup.8, together with the carbon atom to which they are attached, form a cycloalkyl group containing 3 to 7 carbon atoms, or R.sup.7, R.sup.8 and R.sup.9 together with the carbon atom to which they are attached, form a bicycloalkyl group containing 4 to 9 carbon atoms, and Y is a 5- or 6-membered heterocyclic ring excluding pyrazole; and salts thereof.

  以下化合物具有药理特性：##STR1## 其中X为R'(HO)C.dbd.C(CN)--，R.sup.1 (CO)--CH(CN)--或##STR2## R.sup.1和R.sup.2分别为氢或C.sub.1-6烷基，R.sup.3、R.sup.4、R.sup.5和R.sup.6分别为氢、羟基、卤素、硝基、氰基、羧基、C.sub.1-4烷基、C.sub.1-4烷氧基、C.sub.1-4烷硫基、卤素取代的C.sub.1-4烷基、卤素取代的C.sub.1-4烷氧基、卤素取代的C.sub.1-4烷硫基、C.sub.2-5烷氧羰基、可选择取代的苯基、可选择取代的苯氧基、R'R"N--其中R'和R"分别为氢或C.sub.1-4烷基或R'"CONH--其中R'"为C.sub.1-4烷基，或具有以下式--CR.sup.7 R.sup.8 R.sup.9的基团，其中R.sup.7、R.sup.8和R.sup.9分别为C.sub.1-6烷基、卤素取代的C.sub.1-6烷基或可选择取代的苯基，或R.sup.7和R.sup.8与它们连接的碳原子一起形成含有3至7个碳原子的环烷基，或R.sup.7、R.sup.8和R.sup.9与它们连接的碳原子一起形成含有4至9个碳原子的双环烷基，Y为排除吡唑的5-或6-成员杂环环，以及其盐。
• [EN] THIOPHENE -2- CARBOXYLIC ACID - (1H - BENZIMIDAZOL - 2 YL) - AMIDE DERIVATIVES AND RELATED COMPOUNDS AS INHIBITORS OF THE TEC KINASE ITK (INTERLEUKIN -2- INDUCIBLE T CELL KINASE) FOR THE TREATMENT OF INFLAMMATION, IMMUNOLOGICAL AND ALLERGIC DISORDERS<br/>[FR] DERIVES D'ACIDE THIOPHENE-2-CARBOXYLIQUE (1H-BENZIMIDAZOL-2 YL)-AMIDE ET COMPOSES ASSOCIES UTILISES COMME INHIBITEURS DE LA TEC KINASE ITK (KINASE DES LYMPHOCITES INDUCTIBLES PAR L'INTERLEUKINE -2) POUR TRAITER UNE INFLAMMATION ET DES TROUBLES IMMUNOLOGIQUES ET ALLERGIQUES
  申请人：BOEHRINGER INGELHEIM PHARMA

  公开号：WO2005079791A1

  公开（公告）日：2005-09-01

  Disclosed are compounds of formula (I): wherein Ar1, Ar2, R1, R2, R3, R4 and Xa are defined herein. The compounds of the invention inhibit Itk kinase and are therefore useful for treating diseases and pathological conditions involving inflammation, immunological disorders and allergic disorders. Also disclosed are processes for preparing these compounds and to pharmaceutical compositions comprising these compounds.

  揭示了式（I）的化合物：其中Ar1、Ar2、R1、R2、R3、R4和Xa在此定义。该发明的化合物抑制Itk激酶，因此对于治疗涉及炎症、免疫紊乱和过敏疾病的疾病和病理状况是有用的。还公开了制备这些化合物的方法以及包含这些化合物的药物组合物。
• [EN] NOVEL COMPOUND, METHOD FOR PREPARATION THEREOF, AND ANTIFUNGAL COMPOSITION COMPRISING THE SAME<br/>[FR] NOUVEAU COMPOSÉ, PROCÉDÉ DE PRÉPARATION DE CELUI-CI, ET COMPOSITION ANTIFONGIQUE LE COMPRENANT
  申请人：DAE WOONG PHARMA

  公开号：WO2015069011A1

  公开（公告）日：2015-05-14

  Disclosed are a compound having an excellent antifungal activity, a composition containing the same, and its use for prevention and treatment of fungal infectious diseases.

  揭示了一种具有优异抗真菌活性的化合物，以及包含该化合物的组合物，以及其用于预防和治疗真菌感染性疾病的用途。
• 4-isoxazolecarboxamide derivatives
  申请人：Syntex (U.S.A.) Inc.

  公开号：US05001124A1

  公开（公告）日：1991-03-19

  This invention is directed to compounds of the formula (I): ##STR1## wherein R.sup.1 is --OR.sup.4 (where R.sup.4 is hydrogen, lower alkyl, lower hydroxyalkyl, phenyl, phenyl-lower-alkyl, or --(CH.sub.2).sub.n Y where n is an integer from 1 to 4 and Y is morpholino, -SR.sup.5, --C(O)OR.sup.5, --C(O)N(R.sup.6).sub.2, --N(R.sup.6).sub.2, or --N.sup.+ (R.sup.6).sub.3 X.sup.-, in which R.sup.5 is lower alkyl, each R.sup.6 is independently selected from hydrogen or lower alkyl, and X is halogen) or --SR.sup.7 (where R.sup.7 is lower alkyl, phenyl-lower-alkyl, or --(CH.sub.2).sub.n W where W is --N(R.sup.6).sub.2 or --N.sup.+ (R.sup.6).sub.3 X.sup.-, and n, R.sup.6 and X are as previously defined); R.sup.2 is lower alkyl, phenyl or phenyl-lower-alkyl; R.sup.3 is halo, hydroxy, lower alkyl, lower alkoxy, lower haloalkyl, lower haloalkoxy, or --C(O)OR.sup.5 where R.sup.5 is as previously defined; and Z is a bond, 2,5-thienyl or 2,5-furanyl; or a pharmaceutically acceptable salt thereof. These compounds are useful in treating inflammation, autoimmune disease or allograft rejection in mammals.

  本发明涉及式（I）的化合物：##STR1## 其中R.sup.1是--OR.sup.4（其中R.sup.4是氢，低烷基，低羟基烷基，苯基，苯基-低烷基，或--（CH.sub.2）.sub.n Y，其中n是1到4的整数，Y是吗啡啉，-SR.sup.5，--C（O）OR.sup.5，--C（O）N（R.sup.6）.sub.2，--N（R.sup.6）.sub.2或--N.sup.+（R.sup.6）.sub.3X.sup.-，其中R.sup.5是低烷基，每个R.sup.6独立地选自氢或低烷基，而X是卤素）或--SR.sup.7（其中R.sup.7是低烷基，苯基-低烷基或--（CH.sub.2）.sub.n W，其中W是--N（R.sup.6）.sub.2或--N.sup.+（R.sup.6）.sub.3X.sup.-，而n，R.sup.6和X如前所定义）; R.sup.2是低烷基，苯基或苯基-低烷基; R.sup.3是卤素，羟基，低烷基，低烷氧基，低卤代烷基，低卤代烷氧基，或--C（O）OR.sup.5，其中R.sup.5如前所定义; Z是键，2,5-噻吩基或2,5-呋喃基; 或其药学上可接受的盐。这些化合物在治疗哺乳动物的炎症，自身免疫疾病或异体移植排斥方面有用。
• Tec kinase inhibitors
  申请人：Bentzien Martin Joerg

  公开号：US20050209284A1

  公开（公告）日：2005-09-22

  Disclosed are compounds of formula(I): wherein Ar 1 , Ar 2 , R 1 , R 2 , R 3 , R 4 and X a are defined herein. The compounds of the invention inhibit Itk kinase and are therefore useful for treating diseases and pathological conditions involving inflammation, immunological disorders and allergic disorders. Also disclosed are processes for preparing these compounds and to pharmaceutical compositions comprising these compounds.

  本发明公开了式(I)的化合物：其中Ar1、Ar2、R1、R2、R3、R4和Xa的定义如下。本发明的化合物抑制Itk激酶，因此可用于治疗涉及炎症、免疫紊乱和过敏症的疾病和病理条件。本发明还公开了制备这些化合物的方法和包含这些化合物的药物组合物。